São Paulo, August 2020 – The Eurofarma Institute, Eurofarma’s social arm that pursues inclusion through transformative education, has opened registration for its Enem (National High School Exam) preparatory course. “De Olho no Enem” [Looking to the National High School Exam] is free and now will be taught online (via Google Meet) to public school students from all over the country.
Registration is now open at www.institutoeurofarma.com.br and runs through August 30. Public school students in the 3rd year of high school (or who have graduated no more than three years ago) can apply for vacancies.
Classes are taught by Eurofarma Institute teachers and focus on the content required in the Portuguese Language, Mathematics, and Writing exams. The course also offers drills, lectures, and practice exams.
Students will need a device (computer, tablet or smartphone) with internet access to attend classes and carry out the activities on the educational platforms.
|De Olho no Enem [Looking to the National High School Exam]||Approximate workload: 196 hours
Length: 3 months, starting in September and ending on December 17
Target audience: 3rd year high school students (or those who have graduated no more than three years ago) from public schools
About the Eurofarma Institute
Education as a model for transformation
Founded 12 years ago, the Eurofarma Institute seeks to enhance the results of Eurofarma’s social investments in three main areas: Training for Young People and Adults, Complementary Education and Environmental Education. The initiatives developed are always focused on socioeconomic inclusion and sustainable development through quality education. The projects are self-managed, feature partnerships of a pedagogical nature and their purpose is to foster participants’ autonomy and protagonism.
About Eurofarma Group
As the first multinational pharmaceutical company with 100% Brazilian capital, the Eurofarma Group has been operating in the health industry since its establishment in 1972, producing and marketing innovative products and services to improve people’s quality of life. Focused on generating shared value, it operates in the areas of Prescription, Non-Prescription, and Generic Drugs, Hospital, Oncology and Veterinary. In Brazil alone, it offers 313 products, 649 dosage forms, serves 25 medical specialties and covers 89 therapeutic classes, which represent 81% of prescriptions in the brand market.
The Eurofarma Group has own operations in 20 countries, with an industrial park in Brazil and plants in 6 more Latin American countries. Reported sales totaled BRL 5.6 billion in 2019 and the Group employs over 7,000 employees.